Skip to main content
. 2022 Mar;10(5):244. doi: 10.21037/atm-21-4457

Figure 1.

Figure 1

Chemoprevention in mice oral carcinogenesis. (A) Experimental protocol of the 6 groups. (B) Bodyweight changes in the experimental groups. Cumulative incidence of oral dysplasia/carcinoma (C) at week 18 and (D) at week 22. (E) Growth rate of carcinoma occurrence in experimental groups after the drug withdrawal for 4 weeks. The asterisk (*) indicates that the mice were sacrificed at the indicated time points (weeks 8, 14, 18, or 22). NQO, 4-nitroquinoline-N-oxide; SalB, salvianolic acid B; PLC-NP, phospholipid complex loaded nanoparticles.